C.RoyA.KhademS.BrodskyJ
Intelligence tools that aggregate these disparate data streams Orange Book filings, SPC expiry dates by jurisdiction, Paragraph IV litigation dockets, EMA authorization timelines, JCA scoping documents are now infrastructure for anyone making capital allocation decisions in pharmaceutical and medtech markets
Weve tracked GLP-1 use over the last year and weve seen really dramatic increases, and yet, theres not a ton of information available on head to head comparisons, said lead study author Tricia Rodriguez, a principal applied scientist at Truveta Research, a health care data and analytics company
Ask for the dispensing pharmacy, lot information, concentration, testing documentation available to patients, and state license before treatment
The safety profile of dual agonists is similar to pure GLP-1 agonists, with the main difference being slightly higher rates of GI side effects
Licensed New York Providers Every treatment plan begins with a medical evaluation by a licensed provider
